Form C - Offering Statement:
SEC Accession No. 0001670254-21-000178
Filing Date
2021-02-19
Accepted
2021-02-18 20:13:46
Documents
9

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 9729
2 document_1.pdf EX-99 11910729
3 document_2.pdf EX-99 2973448
4 document_3.pdf EX-99 8805114
5 document_4.pdf EX-99 8805093
6 document_5.pdf EX-99 12894382
7 document_6.pdf EX-99 961151
8 document_7.pdf EX-99 1151471
9 documents_list.htm EX-99 118
  Complete submission text file 0001670254-21-000178.txt   63821614
Mailing Address 3401 GRAYS FERRY AVENUE BLDG 176 PHILADELPHIA PA 19146
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 248-513-0760
InnaMed, Inc. (Filer) CIK: 0001773255 (see all company filings)

EIN.: 812693320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-27652 | Film No.: 21651579